<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01474044</url>
  </required_header>
  <id_info>
    <org_study_id>CATS-CO-002</org_study_id>
    <nct_id>NCT01474044</nct_id>
  </id_info>
  <brief_title>To Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis (CAG)</brief_title>
  <official_title>A Phase IV Study to Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xinjiang Biochemical Pharmaceutical Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xinjiang Biochemical Pharmaceutical Co., Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Gastropyloric Complex Capsules are safe and
      effective in the treatment of chronic atrophic gastritis (CAG).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Till now, there is no ideal treatment to chronic atrophic gastritis(CAG). This study is try
      to find a possible treatment to CAG with Gastropyloric Complex Capsules.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effective rate confirmed by histology</measure>
    <time_frame>within 180 days after treatment</time_frame>
    <description>All patients are required to repeat the histology examination after 180 days follow-up is completed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical manifestations including abdominal pain, anorexia, nausea, vomiting, and belching</measure>
    <time_frame>within 180 days after treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">851</enrollment>
  <condition>Chronic Atrophic Gastritis (CAG)</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Gastropyloric Complex Capsules</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gastropylor Complex Capsules</intervention_name>
    <description>3 pills, three times a day, after meal</description>
    <arm_group_label>Gastropyloric Complex Capsules</arm_group_label>
    <other_name>Gastropyloric Extracts and Vit B12 Complex Capsules</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo Comparator</intervention_name>
    <description>Placebo that is same as gastropyloric complex capsules</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-70 years, male or female

          -  Histologically diagnosed CAG

          -  HP negative confirmed by gastric mucosal staining

          -  Signed an written informed consent

        Exclusion Criteria:

          -  CAG with high-grade intraepithelial neoplasia

          -  Severe gastric mucosal erosion or bleeding needing treatment

          -  Active peptic ulcer, GERD, or esophageal stricture

          -  History of upper GI tract surgery

          -  History of malignant diseases

          -  With depression, anxiety neuroses, or hysteria

          -  Heart failure (NYHA class lll or lV), liver disease (ALT ≥ 80 IU/L, AST ≥ 80 IU/L) or
             renal disease(Cr ≥ 150 ummol/L)

          -  Uncontrolled hypertension

          -  Uncontrolled diabetes

          -  Alcohol abuse

          -  Drug allergy

          -  Participated in another investigational study within 4 weeks prior to Visit 0

          -  Pregnancy, be a nursing mother or without conception control

          -  There is any concern by the investigator regarding the safe participation of the
             participant in the study or for any other reason; the investigator considers the
             participant inappropriate for participation in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kaichun WU, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xijing Hospital of Digestive Diseases</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Xijing Hospital of Digestive Diseases</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2011</study_first_submitted>
  <study_first_submitted_qc>November 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2011</study_first_posted>
  <last_update_submitted>July 6, 2013</last_update_submitted>
  <last_update_submitted_qc>July 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 9, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrophy</mesh_term>
    <mesh_term>Gastritis</mesh_term>
    <mesh_term>Gastritis, Atrophic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin B Complex</mesh_term>
    <mesh_term>Vitamin B 12</mesh_term>
    <mesh_term>Hydroxocobalamin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

